Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...
Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...
Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...
Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.
Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...
HYDERABAD (Reuters) -Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating ...
"People come together, operators, with their supervisors at 6 a.m. every morning, and they talk about what issues they have and how they propose to solve it. Those get escalated through all levels of ...
Eli Lilly will now be directly reaching into that ... executive vice president of life sciences at Gifthealth, said in a statement. “Through Gifthealth’s relationship with LillyDirect, we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback